[1] O’DOWD BF, HEIBER M, CHAN A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene. 1993;136(1-2):355-360.
[2] TATEMOTO K, HOSOYA M, HABATA Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251(2):471-476.
[3] 李莉芳, 肖建华. Apelin/APJ系统在心血管疾病中的生理与病理作用[J]. 中南医学科学杂志,2019,47(5):452-457.
[4] KAWAMATA Y, HABATA Y, FUKUSUMI S, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta. 2001;1538(2-3):162-171.
[5] GILBERT JS. From apelin to exercise: emerging therapies for management of hypertension in pregnancy. Hypertens Res. 2017;40(6): 519-525.
[6] WANG K, JU Z, YONG Y, et al. The Effects of Electroacupuncture on the Apelin/APJ System in the Spinal Cord of Rats With Inflammatory Pain. Anesth Analg. 2016;123(6):1603-1610.
[7] XIONG Q, HE W, WANG H, et al. Effect of the spinal apelinAPJ system on the pathogenesis of chronic constriction injuryinduced neuropathic pain in rats. Mol Med Rep. 2017;16(2):1223-1231.
[8] 杨丽红, 杜元灏, 李晶. 电针对脑梗死大鼠脑血管内皮细胞Apelin-APJ系统的影响[J]. 针刺研究,2017,42(1):9-13.
[9] XIN Q, CHENG B, PAN Y, et al. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation. Peptides. 2015;63:55-62.
[10] CHU H, YANG X, HUANG C, et al. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4. Cerebrovasc Dis. 2017;44(1-2):10-25.
[11] HARFORD-WRIGHT E, ANDRE-GREGOIRE G, JACOBS KA, et al. Pharmacological targeting of apelin impairs glioblastoma growth. Brain. 2017;140(11):2939-2954.
[12] BAO H J, ZHANG L, HAN WC, et al. Apelin-13 attenuates traumatic brain injury-induced damage by suppressing autophagy. Neurochem Res. 2015;40(1):89-97.
[13] HAGHPARAST E, ESMAEILI-MAHANI S, ABBASNEJAD M, et al. Apelin-13 ameliorates cognitive impairments in 6-hydroxydopamine-induced substantia nigra lesion in rats. Neuropeptides. 2018;68:28-35.
[14] YAN J, WANG A, CAO J, et al. Apelin/APJ system: an emerging therapeutic target for respiratory diseases. Cell Mol Life Sci. 2020; 77(15):2919-2930.
[15] ZHANG H, CHEN S, ZENG M, et al. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-kappaB Pathway and NLRP3 Inflammasome Activation. Cell Physiol Biochem. 2018;49(5):1918-1932.
[16] FAN XF, XUE F, ZHANG YQ, et al. The Apelin-APJ axis is an endogenous counterinjury mechanism in experimental acute lung injury. Chest. 2015;147(4):969-978.
[17] 李莉芳, 肖建华. Apelin/APJ系统在心血管疾病中的生理与病理作用[J]. 中南医学科学杂志,2019,47(5):452-457.
[18] HASHIMOTO T, KIHARA M, ISHIDA J, et al. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2006,26(6):1267-1272.
[19] XIE H, LUO G, ZHENG Y, et al. Lowered circulating apelin is significantly associated with an increased risk for hypertension: A meta-analysis. Clin Exp Hypertens. 2017;39(5):435-440.
[20] 黄扬, 闻慧娟, 贾海波, 等. 血清脂肪因子vaspin、apelin、chemerin与老年高血压病人血压变异的相关性分析[J]. 热带医学杂志,2019, 19(6):743-746.
[21] DUFT K, SCHANZ M, PHAM H, et al. 17beta-Estradiol-induced interaction of estrogen receptor alpha and human atrial essential myosin light chain modulates cardiac contractile function. Basic Res Cardiol. 2017;112(1):1.
[22] LIU K, FANG C, SHEN Y, et al. Hypoxia-inducible factor 1a induces phenotype switch of human aortic vascular smooth muscle cell through PI3K/AKT/AEG-1 signaling. Oncotarget. 2017;8(20):33343-33352.
[23] ZHAO H, HAN T, HONG X, et al. Adipose differentiationrelated protein knockdown inhibits vascular smooth muscle cell proliferation and migration and attenuates neointima formation. Mol Med Rep. 2017; 16(3):3079-3086.
[24] ROSTAMZADEH F, NAJAFIPOUR H, YEGANEH-HAJAHMADI M, et al. Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension. Clin Exp Pharmacol Physiol. 2018;45(2):187-197.
[25] MUGHAL A, SUN C, O’ROURKE ST. Apelin Reduces Nitric Oxide-Induced Relaxation of Cerebral Arteries by Inhibiting Activation of Large-Conductance, Calcium-Activated K Channels. J Cardiovasc Pharmacol. 2018;71(4):223-232.
[26] ISHIMARU Y, SHIBAGAKI F, YAMAMURO A, et al. An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice. Sci Rep.2017;7(1):15062.
[27] LI H, KENTISH SJ, WITTERT GA, et al. Apelin modulates murine gastric vagal afferent mechanosensitivity. Physiol Behav. 2018;194:466-473.
[28] GUO L, LI Q, WANG W, et al. Apelin inhibits insulin secretion in pancreatic beta-cells by activation of PI3-kinase-phosphodiesterase 3B. Endocr Res. 2009;34(4):142-154.
[29] ANTUSHEVICH H, BIERLA J, PAWLINA B, et al. Apelin’s effects on young rat gastrointestinal tract maturation. Peptides. 2015;65:1-5.
[30] BULBUL M, SINEN O, BIRSEN I, et al. Peripheral apelin-13 administration inhibits gastrointestinal motor functions in rats: The role of cholecystokinin through CCK1 receptor-mediated pathway. Neuropeptides. 2017;63:91-97.
[31] BIRSEN I, GEMICI B, ACAR N, et al. The role of apelin in the healing of water-immersion and restraint stress-induced gastric damage. J Physiol Sci. 2017;67(3):373-385.
[32] BULBUL M, SINEN O, GOK M, et al. Apelin-13 inhibits gastric motility through vagal cholinergic pathway in rats. Am J Physiol Gastrointest Liver Physiol. 2018;314(2):G201-G210.
[33] MELGAR-LESMES P, PERRAMON M, JIMENEZ W. Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis. Cells. 2019;8(11):1311.
[34] MELGAR-LESMES P, PAUTA M, REICHENBACH V, et al. Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes. Gut. 2011;60(10):1404-1411.
[35] REICHENBACH V, FERNANDEZ-VARO G, CASALS G, et al. Adenoviral dominant-negative soluble PDGFRbeta improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats. J Hepatol. 2012;57(5):967-973.
[36] DAI E, ZHANG L, YE L, et al. Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B. Int J Infect Dis. 2017;59:124-130.
[37] YOSHIYA S, SHIRABE K, IMAI D, et al. Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy. J Gastroenterol. 2015;50(5):573-582.
[38] CHEN L, ZHOU T, WHITE T, et al. The apelin-apelin receptor axis triggers cholangiocyte proliferation and liver fibrosis during mouse models of cholestasis. Hepatology. 2020.
[39] GE Y, LI Y, CHEN Q, et al. Adipokine apelin ameliorates chronic colitis in Il-10(-/-) mice by promoting intestinal lymphatic functions. Biochem Pharmacol. 2018;148:202-212.
[40] CHEN Z, WU D, LI L, et al. Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury. DNA Cell Biol. 2016;35(12):766-775.
[41] HUANG Z, WU L, CHEN L. Apelin/APJ system: A novel potential therapy target for kidney disease. J Cell Physiol. 2018;233(5):3892-3900.
[42] BOULKEROUA C, AYARI H, KHALFAOUI T, et al. Apelin-13 Regulates Vasopressin-Induced Aquaporin-2 Expression and Trafficking in Kidney Collecting Duct Cells. Cell Physiol Biochem. 2019;53(4):687-700.
[43] SHUANG L, JIDONG W, HONGJUAN P, et al. Effects of apelin on proliferation and apoptosis in rat ovarian granulosa cells. Clin Exp Obstet Gynecol. 2016;43(3):409-413.
[44] RAK A, DRWAL E, RAME C, et al. Expression of apelin and apelin receptor (APJ) in porcine ovarian follicles and in vitro effect of apelin on steroidogenesis and proliferation through APJ activation and different signaling pathways. Theriogenology. 2017;96:126-135.
[45] ANTUSHEVICH H, WOJCIK M. Review: Apelin in disease. Clin Chim Acta. 2018;483:241-248.
[46] GOURDY P, CAZALS L, THALAMAS C, et al. Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp. Diabetes Obes Metab. 2018;20(1):157-164.
[47] WANG W, MCKINNIE SM, FARHAN M, et al. Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System. Hypertension. 2016;68(2):365-377.
[48] BERTRAND C, VALET P, CASTAN-LAURELL I. Apelin and energy metabolism. Front Physiol. 2015;6:115.
[49] BERTRAND C, PRADERE JP, GEOFFRE N, et al. Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism. Endocrine. 2018;60(1):112-121.
[50] YUZBASHIAN E, ZARKESH M, ASGHARI G, et al. Is apelin gene expression and concentration affected by dietary intakes? A systematic review. Crit Rev Food Sci Nutr. 2018;58(4):680-688.
[51] PATEL SJ, SANJANA NE, KISHTON RJ, et al. Identification of essential genes for cancer immunotherapy. Nature. 2017;548(7669):537-542.
[52] IZGUT-UYSAL VN, GEMICI B, BIRSEN I, et al. The effect of apelin on the functions of peritoneal macrophages. Physiol Res. 2017;66(3):489-496.
[53] GE Y, LI Y, CHEN Q, et al. Adipokine apelin ameliorates chronic colitis in Il-10(-/-) mice by promoting intestinal lymphatic functions. Biochem Pharmacol. 2018;148:202-212.
[54] MAYEUR S, WATTEZ JS, LUKASZEWSKI MA, et al. Apelin Controls Fetal and Neonatal Glucose Homeostasis and Is Altered by Maternal Undernutrition. Diabetes. 2016;65(3):554-560.
[55] VAN MIEGHEM T, DOHERTY A, BACZYK D, et al. Apelin in Normal Pregnancy and Pregnancies Complicated by Placental Insufficiency. Reprod Sci. 2016;23(8):1037-1043.
[56] GILBERT JS. From apelin to exercise: emerging therapies for management of hypertension in pregnancy. Hypertens Res. 2017;40(6): 519-525.
[57] ZHOU Q, CHEN L, TANG M, et al. Apelin/APJ system: A novel promising target for anti-aging intervention. Clin Chim Acta. 2018;487:233-240.
[58] CHNG SC, HO L, TIAN J, et al. ELABELA: a hormone essential for heart development signals via the apelin receptor. Developmental Cell. 2013;27(6):672-680.
[59] PAULI A, NORRIS ML, VALEN E, et al. Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science. 2014; 343(6172):1248636.
[60] HO L, TAN SY, WEE S, et al. ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway. Cell Stem Cell. 2015;17(4):435-447.
[61] SATO T, SATO C, KADOWAKI A, et al. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage. Cardiovasc Res. 2017;113(7):760-769.
[62] YANG P, READ C, KUC RE, et al. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension. Circulation. 2017;135(12):1160-1173.
[63] ACIK DY, BANKIR M, BAYLAN FA, et al. Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia? BMC Cancer. 2019;19(1):1086.
[64] GANGULY D, CAI C, SIMS MM, et al. APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade. Pharmaceuticals (Basel). 2019;12(1):45.
[65] YI Y, TSAI SH, CHENG JC, et al. APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner. Gynecol Oncol. 2017;147(3):663-671.
[66] DENG C, CHEN H, YANG N, et al. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling. J Biol Chem. 2015;290(30):18261-18268.
[67] XU C, WANG F, CHEN Y, et al. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury. Am J Physiol Renal Physiol. 2020;318(5):F1122-F1135.
[68] SCHREIBER CA, HOLDITCH SJ, GENEROUS A, et al. Sustained ELABELA Gene Therapy in High-salt Diet-induced Hypertensive Rats. Curr Gene Ther. 2017;16(5):349-360.
[69] DEVIC E, PAQUEREAU L, VERNIER P, et al. Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis. Mech Dev. 1996;59(2):129-140.
[70] HO L, VAN DIJK M, CHYE S, et al. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science. 2017;357(6352):707-713.
[71] DENG C, CHEN H, YANG N, et al. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling. J Biol Chem. 2015;290(30):18261-18268.
[72] HUANG R, ZHU J, ZHANG L, et al. Is ELABELA a reliable biomarker for hypertensive disorders of pregnancy? Pregnancy Hypertens. 2019;17:226-232.
[73] WANG J, LI N, GAO F, et al. Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure. J Renin Angiotensin Aldosterone Syst. 2015;16(3): 553-558.
[74] YANG J, FENG X, ZHOU Q, et al. Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex. Proc Natl Acad Sci U S A. 2016; 113(38):E5628-E5635.
[75] PERJES A, KILPIO T, ULVILA J, et al. Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart. Basic Res Cardiol. 2016;111(1):2.
[76] WANG Q, WANG GQ, PANG LX, et al. Changes of apelin and its receptor in lung tissue of rats with pulmonary hypertension induced by monocrotaline. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013;29(2):101-105. |